GRRR:NASDAQGorilla Technology Group Inc. Analysis
Data as of 2026-08-31 - not real-time
$14.93
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Gorilla Technology Group Inc. trades at $14.93, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has gained 22.9%. RSI sits at 51.8, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $11.78 and resistance around $16.48.
On valuation the read is undervalued — earnings multiple of 13.7 versus a 35.7 sector average, below the peer group. The average analyst target implies 146.1% above today's level. Revenue is growing at 138.0% on a -35.4% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 86.7%, a beta of 2.64 and a maximum drawdown of 55.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
On valuation the read is undervalued — earnings multiple of 13.7 versus a 35.7 sector average, below the peer group. The average analyst target implies 146.1% above today's level. Revenue is growing at 138.0% on a -35.4% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 86.7%, a beta of 2.64 and a maximum drawdown of 55.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
Top Market Events
By Brian Lantier, CFA NASDAQ: GRRR READ THE FULL GRRR RESEARCH REPORT WHAT’S NEW After the market closed on August...Gorilla Technology Group Inc. NASDAQ:GRRR stock fell in premarket trading Tuesday after the company issued 2027 revenue...Gorilla Technology Group Inc. NASDAQ:GRRR shares closed at $15.83, down 1.4%, on August 24. The stock fell 13.1% to...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 13.69
- MACD momentum is positive
- 30-day price change of +22.9%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 13.7 versus sector average of 35.7
- Trading above the 200-day average of 13.69
- Analyst targets imply +146.1% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 13.7 versus sector average of 35.7
- Negative profit margin of -35.4%
- Analyst targets imply +146.1% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth138.00%
Profit Margin-35.38%
P/E Ratio13.7
ROE-36.92%
ROA-8.76%
Debt/Equity43.59
P/B Ratio2.4
Op. Cash Flow$-20480236
Free Cash Flow$41.5M
Industry P/E35.7
Technical Analysis
TrendNeutral
RSI51.8
Support$11.78
Resistance$16.48
MA 20$14.50
MA 50$14.84
MA 200$13.69
MACDBullish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair Value$56.74
Target Price$36.75
Upside/Downside146.15%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.64
Volatility86.75%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.